4.5 Article

Glutaminase and MMP-9 Downregulation in Cortex and Hippocampus of LPA1 Receptor Null Mice Correlate with Altered Dendritic Spine Plasticity

Journal

FRONTIERS IN MOLECULAR NEUROSCIENCE
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnmol.2017.00278

Keywords

lysophosphatidic acid; glutaminase; glutamate; matrix metalloproteinases; rodent knockout model; synaptic plasticity

Categories

Funding

  1. Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III)
  2. European Regional Development Funds-European Union (ERDF-EU) [RD16/0017/001, RD12/0028/0013, RD12/0028/0001, RD12/0028/0002]
  3. Ministerio de Economia y Competitividad, Proyectos de investigacion en Salud [PI16/01698, PI16/01953, FIS PI12/01431, FIS PI15/00796, SAF2015-64501-R, SAF2013-40592-R]
  4. Excellence Grant-Regional Andalusian government [CVI-6656, CTS-8221]

Ask authors/readers for more resources

Lysophosphatidic acid (LPA) is an extracellular lipid mediator that regulates nervous system development and functions acting through G protein-coupled receptors (GPCRs). Here we explore the crosstalk between LPA(1) receptor and glutamatergic transmission by examining expression of glutaminase (GA) isoforms in different brain areas isolated from wild-type (WT) and KOLPA(1) mice. Silencing of LPA(1) receptor induced a severe down-regulation of Gls-encoded long glutaminase protein variant (KGA) (glutaminase gene encoding the kidney-type isoforms, GLS) protein expression in several brain regions, particularly in brain cortex and hippocampus. Immunohistochemical assessment of protein levels for the second type of glutaminase (GA) isoform, glutaminase gene encoding the liver-type isoforms (GLS2), did not detect substantial differences with regard to WT animals. The regional mRNA levels of GLS were determined by real time RT-PCR and did not show significant variations, except for prefrontal and motor cortex values which clearly diminished in KO mice. Total GA activity was also significantly reduced in prefrontal and motor cortex, but remained essentially unchanged in the hippocampus and rest of brain regions examined, suggesting activation of genetic compensatory mechanisms and/or post-translational modifications to compensate for KGA protein deficit. Remarkably, Golgi staining of hippocampal regions showed an altered morphology of glutamatergic pyramidal cells dendritic spines towards a less mature filopodia-like phenotype, as compared with WT littermates. This structural change correlated with a strong decrease of active matrix-metalloproteinase (MMP) 9 in cerebral cortex and hippocampus of KOLPA(1) mice. Taken together, these results demonstrate that LPA signaling through LPA(1) influence expression of the main isoenzyme of glutamate biosynthesis with strong repercussions on dendritic spines maturation, which may partially explain the cognitive and learning defects previously reported for this colony of KOLPA(1) mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Clinical Neurology

Animal and Cellular Models of Alzheimer's Disease: Progress, Promise, and Future Approaches

Laura Trujillo-Estrada, Elisabeth Sanchez-Mejias, Raquel Sanchez-Varo, Juan Antonio Garcia-Leon, Cristina Nunez-Diaz, Jose Carlos Davila, Javier Vitorica, Frank M. LaFerla, Ines Moreno-Gonzalez, Antonia Gutierrez, David Baglietto-Vargas

Summary: Alzheimer's disease is an incurable neurodegenerative disease affecting over 45 million people worldwide, with transgenic mouse models playing a significant role in elucidating its pathogenic mechanisms. However, limitations of current animal models highlight the need for more reliable models and human cellular models to improve the success rate of translating preclinical therapies into human treatments.

NEUROSCIENTIST (2022)

Review Biochemistry & Molecular Biology

Age-related immune alterations and cerebrovascular inflammation

Carson E. Finger, Ines Moreno-Gonzalez, Antonia Gutierrez, Jose Felix Moruno-Manchon, Louise D. McCullough

Summary: Aging is closely associated with chronic systemic inflammation and the development of various age-related diseases, including vascular disease. Poor outcomes after stroke in aged patients are predicted due to altered immune response, which differs from that of younger patients.

MOLECULAR PSYCHIATRY (2022)

Article Immunology

In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue

Zhi Li, Zewen K. Tuong, Isaac Dean, Claire Willis, Fabrina Gaspal, Remi Fiancette, Suaad Idris, Bethany Kennedy, John R. Ferdinand, Ana Penalver, Mia Cabantous, Syed Murtuza Baker, Jeremy W. Fry, Gianluca Carlesso, Scott A. Hammond, Simon J. Dovedi, Matthew R. Hepworth, Menna R. Clatworthy, David R. Withers

Summary: This study used photoconversion to label tumor-infiltrating lymphocytes and found that TCF-1(+) T cells migrate continuously between the tumor and draining lymphoid tissue. The study also revealed the transcriptional characteristics of CD8 T cells in the tumor and their dynamic changes in retention and egress.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Medicine, General & Internal

The impact of hypoxia on B cells in COVID-19

Prasanti Kotagiri, Federica Mescia, Aimee L. Hanson, Lorinda Turner, Laura Bergamaschi, Ana Penalver, Nathan Richoz, Stephen D. Moore, Brian M. Ortmann, Benjamin J. Dunmore, Michael D. Morgan, Zewen Kelvin Tuong, Berthold Gottgens, Mark Toshner, Christoph Hess, Patrick H. Maxwell, Menna R. Clatworthy, James A. Nathan, John R. Bradley, Paul A. Lyons, Natalie Burrows, Kenneth G. C. Smith

Summary: Early and persistent defects in B cell subsets in COVID-19 are associated with hypoxia. Early oxygen therapy may be beneficial in correcting these immune deficiencies and improving outcomes.

EBIOMEDICINE (2022)

Article Medicine, Research & Experimental

The synthetic molecule stauprimide impairs cell growth and migration in triple-negative breast cancer

P. Carrillo, M. Bernal, C. Tellez-Quijona, A. D. Marrero, I. Vidal, L. Castilla, C. Caro, A. Dominguez, M. L. Garcia-Martin, A. R. Quesada, M. A. Medina, B. Martinez-Poveda

Summary: Stauprimide inhibits cell proliferation and migration in triple-negative breast cancer cells, both in vitro and in vivo. It exerts its effects by modulating ERK1/2, Akt, and p38 MAPK signaling pathways, and downregulating MYC. These findings suggest that stauprimide could be a promising therapeutic agent for triple-negative breast cancer.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Clinical Neurology

Identification of Potential Visceral Pain Biomarkers in Colon Exudates from Mice with Experimental Colitis: An Exploratory In Vitro Study

Elsa Cisneros, Anabel Martinez-Padilla, Casimiro Cardenas, Javier Marquez, Arantxa Ortega de Mues, Carolina Roza

Summary: Chronic visceral pain is difficult to diagnose and treat. This study used a mouse model of colitis to identify proteins involved in the mechanism of chronic visceral pain. High-resolution mass spectrometry was used to evaluate the secreted proteins during acute distension. The findings suggest potential biomarkers and targets for diagnosing and treating chronic visceral pain.

JOURNAL OF PAIN (2023)

Article Oncology

Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines

Juan De los Santos-Jimenez, Tracy Rosales, Bookyung Ko, Jose A. Campos-Sandoval, Francisco J. Alonso, Javier Marquez, Ralph J. DeBerardinis, Jose M. Mates

Summary: Using the GLS inhibitor CB-839, we observed significant changes in glutamine metabolism in three glioblastoma cell lines, including alterations in the tricarboxylic acid cycle and nucleotide biosynthesis pathways. The T98G cell line showed the most pronounced metabolite level modifications and increased levels of acetylated and methylated metabolites. CB-839 treatment also resulted in decreased levels of pyrimidine biosynthesis metabolites and accumulation of intermediate metabolites in the de novo purine nucleotide biosynthesis pathway. These findings provide insights for the development of future combination therapies with CB-839.

CANCERS (2023)

Article Clinical Neurology

Acute intrahippocampal administration of melanin-concentrating hormone impairs memory consolidation and decreases the expression of MCHR-1 and TrkB receptors

Vicente Ruiz-Viroga, Marialuisa de Ceglia, Laura Morelli, Eduardo M. Castano, Eduardo Blanco Calvo, Juan Suarez, Fernando Rodriguez de Fonseca, Pablo Galeano, Patricia Lagos

Summary: Interest in the role of melanin-concentrating hormone (MCH) in memory processes has grown, but studies have provided contradictory findings. This study investigated the effects of MCH on memory consolidation and the BDNF/TrkB system. The results showed that high doses of MCH impaired memory consolidation, but this effect could be reversed by a co-administration with the MCHR-1 antagonist ATC-0175. Additionally, MCH decreased the expression of MCHR-1 and TrkB, linking both endogenous systems to memory processes.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Article Neurosciences

Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer's disease hippocampus

Clara Munoz-Castro, Marina Mejias-Ortega, Elisabeth Sanchez-Mejias, Victoria Navarro, Laura Trujillo-Estrada, Sebastian Jimenez, Juan Antonio Garcia-Leon, Juan Jose Fernandez-Valenzuela, Maria Virtudes Sanchez-Mico, Carmen Romero-Molina, Ines Moreno-Gonzalez, David Baglietto-Vargas, Marisa Vizuete, Antonia Gutierrez, Javier Vitorica

Summary: Monocyte-derived cells infiltrate the brain parenchyma in advanced stages of Alzheimer's disease (AD), acquiring a microglial-like morphology and contributing to plaque-associated myeloid cell heterogeneity. These findings provide an opportunity to develop targeted therapies for both microglia and peripheral immune cells to modulate amyloid pathology and gain a better understanding of the immunological mechanisms underlying AD progression.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Review Pharmacology & Pharmacy

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

Miriam Bettinetti-Luque, Laura Trujillo-Estrada, Eduardo Garcia-Fuentes, Juana Andreo-Lopez, Raquel Sanchez-Varo, Lourdes Garrido-Sanchez, Angela Gomez-Mediavilla, Manuela G. Lopez, Melissa Garcia-Caballero, Antonia Gutierrez, David Baglietto-Vargas

Summary: Adipose tissue is an important endocrine organ that plays a crucial role in energy metabolism and immune response. Recent studies have shown that the adipose tissue can affect brain function through adipokines, which may have implications for the development and treatment of Alzheimer's disease.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Two structurally defined Aβ polymorphs promote different pathological changes in susceptible mice

Ruben Gomez-Gutierrez, Ujjayini Ghosh, Wai-Ming Yau, Nazaret Gamez, Katherine Do, Carlos Kramm, Hamid Shirani, Laura Vegas-Gomez, Jonathan Schulz, Ines Moreno-Gonzalez, Antonia Gutierrez, K. Peter R. Nilsson, Robert Tycko, Claudio Soto, Rodrigo Morales

Summary: The study examines the seeding properties of two structurally defined synthetic misfolded Aβ strains (2F and 3F) and their different pathological features, including aggregation rates, plaque formation, tropism to specific brain regions, recruitment of different Aβ peptides, and induction of microglial and astroglial responses. Moreover, the study analyzes the atomic-level characterization of purified Aβ polymorphs and provides relevant information on the pathological significance of misfolded Aβ strains.

EMBO REPORTS (2023)

Article Biochemistry & Molecular Biology

Comparing RNA extraction methods to face the variations in RNA quality using two human biological matrices

J. Ortega-Pinazo, M. J. Pacheco-Rodriguez, P. J. Serrano-Castro, B. Martinez, M. J. Pinto-Medel, J. M. Gomez-Zumaquero, A. Lago-Sampedro, B. Garcia-Diaz, Guillermo Estivill-Torrus, Pedro Emilio Ferro Gallego

Summary: This study compares different RNA extraction methods and finds that QIAcube and semi-automated extraction methods are the best options due to their lower variability, good functionality, and lower cost. These findings are significant for researchers or research service platforms, emphasizing the importance of selecting the appropriate RNA extraction method in each experimental procedure or traceability study.

MOLECULAR BIOLOGY REPORTS (2023)

Review Biochemistry & Molecular Biology

Microbiome Alterations and Alzheimer's Disease: Modeling Strategies with Transgenic Mice

Juan Antonio Lopez-Villodres, Alejandro Escamilla, Silvia Mercado-Saenz, Carmen Alba-Tercedor, Luis Manuel Rodriguez-Perez, Isabel Arranz-Salas, Raquel Sanchez-Varo, Diego Bermudez

Summary: In the last decade, the microbiota-gut-brain axis has become increasingly important in the study of neurodegenerative and metabolic disorders such as Alzheimer's disease and diabetes. A balanced gut microbiota plays a crucial role in maintaining the intestinal barrier and immune system, while dysbiosis can lead to immune dysregulation and neuroinflammation. In addition, harmful microbial products can cross the blood-brain barrier and contribute to the progression of Alzheimer's disease.

BIOMEDICINES (2023)

No Data Available